Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies.

Trial Profile

A Phase II Study of Deoxycoformycin (DCF) in Lymphoid Malignancies.

Phase of Trial: Phase II

Latest Information Update: 24 Nov 2018

At a glance

  • Drugs Pentostatin (Primary)
  • Indications Chronic lymphocytic leukaemia; Cutaneous T-cell lymphoma; Lymphoproliferative disorders; Peripheral T-cell lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2009 Inclusion and exclusion criteria amended from NCT.
    • 14 Jul 2009 Actual number of patients (60) added as reported by ClinicalTrials.gov.
    • 06 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top